Alain Fourquet mainly focuses on Breast cancer, Surgery, Radiation therapy, Internal medicine and Oncology. The subject of his Breast cancer research is within the realm of Cancer. His work deals with themes such as Clinical trial and Hazard ratio, which intersect with Surgery.
His Radiation therapy research includes elements of Whole Breast Irradiation, Cosmesis, Mammary gland and Mastectomy, Lumpectomy. The study incorporates disciplines such as Gastroenterology and Gynecology in addition to Internal medicine. The concepts of his Oncology study are interwoven with issues in Adjuvant therapy, Ovarian cancer and Cohort.
Breast cancer, Internal medicine, Radiation therapy, Oncology and Surgery are his primary areas of study. The various areas that Alain Fourquet examines in his Breast cancer study include Stage and Radiology. His research on Internal medicine frequently connects to adjacent areas such as Gastroenterology.
His study explores the link between Radiation therapy and topics such as Nuclear medicine that cross with problems in Tomotherapy and Radiation treatment planning. His biological study spans a wide range of topics, including Gynecology, Metastasis and Early breast cancer. His Surgery study frequently involves adjacent topics like Breast surgery.
Alain Fourquet spends much of his time researching Breast cancer, Radiation therapy, Internal medicine, Oncology and Radiology. His Breast cancer research integrates issues from Stage, Nuclear medicine and Lymph node. Surgery covers Alain Fourquet research in Radiation therapy.
His Surgery study combines topics in areas such as Toxicity and Cohort. His Oncology research is multidisciplinary, incorporating perspectives in Randomized controlled trial, Incidence and Trastuzumab. His work in Radiology addresses issues such as Single Center, which are connected to fields such as Tomotherapy.
His main research concerns Breast cancer, Radiation therapy, Internal medicine, Oncology and Radiology. His research on Breast cancer focuses in particular on Mastectomy. His biological study spans a wide range of topics, including Retrospective cohort study and Hazard ratio.
His Oncology study incorporates themes from Incidence, Cumulative incidence, Trastuzumab, Randomized controlled trial and Cohort. The Radiology study combines topics in areas such as Concomitant and Cardiotoxicity. His Surgery research incorporates elements of Pulmonary toxicity, Toxicity and Acute toxicity.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Impact of a Higher Radiation Dose on Local Control and Survival in Breast-Conserving Therapy of Early Breast Cancer: 10-Year Results of the Randomized Boost Versus No Boost EORTC 22881-10882 Trial
Harry Bartelink;Jean-Claude Horiot;Philip M. Poortmans;Henk Struikmans.
Journal of Clinical Oncology (2007)
Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation.
Harry Bartelink;Jean-Claude Horiot;Philip Poortmans;Henk Struikmans.
The New England Journal of Medicine (2001)
Internal mammary and medial supraclavicular irradiation in breast cancer
P.M.P. Poortmans;S. Collette;C. Kirkove;E. van Limbergen.
The New England Journal of Medicine (2015)
Male breast cancer
Ian S Fentiman;Alain Fourquet;Gabriel N Hortobagyi.
The Lancet (2006)
Age as prognostic factor in premenopausal breast carcinoma.
A. de la Rochefordière;F. Campana;J. Fenton;J.R. Vilcoq.
The Lancet (1993)
Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up.
Alain Fourquet;François Campana;Brigitte Zafrani;Véronique Mosseri.
International Journal of Radiation Oncology Biology Physics (1989)
Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6
S.M. Scholl;A. Fourquet;B. Asselain;J.Y. Pierga.
European Journal of Cancer (1994)
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial
Harry Bartelink;Philippe Maingon;Philip Poortmans;Caroline Weltens.
Lancet Oncology (2015)
The influence of patient, tumor and treatment factors on the cosmetic results after breast-conserving therapy in the EORTC 'boost vs. no boost' trial
Conny Vrieling;Laurence Collette;Alain Fourquet;Willem J. Hoogenraad.
Radiotherapy and Oncology (2000)
Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer
P.A. Cabanes;R.J. Salmon;J.R. Vilcoq;J.C. Durand.
The Lancet (1992)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: